C. Noguès

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
To confirm several recent studies pointing to loss of heterozygosity (LOH) at BRCA2 as a prognostic factor in sporadic breast cancer, we examined this genetic alteration in a large series of human primary breast tumours for which long-term patient outcomes were known. LOH at BRCA2 correlated only with low oestrogen and progesterone receptor content.(More)
  • 1